Skip Navigation



QJM Advance Access published online on November 15, 2005

QJM, doi:10.1093/qjmed/hci141
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/1/33    most recent
hci141v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lenton, J.
Right arrow Articles by Nash, J.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lenton, J.
Right arrow Articles by Nash, J.R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: Journals.permissions@oxfordjournals.org
Received August 17, 2005
Revised October 2, 2005

Original paper

Does temporal artery biopsy influence the management of temporal arteritis?

J. Lenton 1, R. Donnelly 1 *, and J.R. Nash 1

1 From the Department of Vascular Surgery, Derby Hospitals NHS Foundation Trust, Derby, and School of Medical & Surgical Sciences, University of Nottingham, Nottingham, UK

* To whom correspondence should be addressed.
R. Donnelly, E-mail: richard.donnelly{at}nottingham.ac.uk


   Abstract

Background: Temporal arteritis (TA) is the commonest form of primary vasculitis. Symptoms are variable, and therefore the diagnosis (or exclusion) of TA is often difficult. Surgeons are frequently asked to perform a temporal artery biopsy (TAB), but whether the histological result actually influences clinical management is unclear.

Aim: To assess whether, in routine clinical practice, a TAB affects clinical decision-making in patients with suspected TA.

Design: Retrospective audit.

Methods: All patients who underwent a TAB in a single hospital over a 2-year period were identified. This included patients referred from different specialist departments. Individual patient records were examined to document the TAB result, and in particular, the timings of commencement and discontinuation of corticosteroid therapy.

Results: A total of 44 patients were included. TAB was positive in seven patients and negative in 37. In 31, there was no change in their clinical management despite a negative biopsy result: 18 continued with corticosteroids for >6 months with a clinical diagnosis of TA, and in 13 patients a decision to stop steroids, or an alternative diagnosis, was made before the biopsy result was known.

Discussion: In this retrospective study, only a small number of TABs provided positive histological confirmation of TA, and in most patients undergoing TAB, there was little evidence that clinical decision-making with respect to corticosteroid therapy was influenced by the TAB result.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
C Mukhtyar, L Guillevin, M C Cid, B Dasgupta, K de Groot, W Gross, T Hauser, B Hellmich, D Jayne, C G M Kallenberg, et al.
EULAR recommendations for the management of large vessel vasculitis
Ann Rheum Dis, March 1, 2009; 68(3): 318 - 323.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, January 14, 2006; 332(7533): 128 - 128.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.